...
首页> 外文期刊>Respiratory Research >TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells
【24h】

TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells

机译:TWEAK增强TGF-β诱导的人支气管上皮细胞上皮-间质转化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BackgroundChronic airway inflammatory disorders, such as asthma, are characterized by airway inflammation and remodeling. Chronic inflammation and damage to the airway epithelium cause airway remodeling, which is associated with improper epithelial repair, and is characterized by elevated expression of transforming growth factor-β (TGF-β). Epithelial-mesenchymal transition (EMT) is an important mechanism during embryonic development and tissue remodeling whereby epithelial cells gain the capacity to increase motility by down-regulation of epithelial markers and up-regulation of mesenchymal markers. TGF-β is a central inducer of EMT, and TGF-β-induced EMT is enhanced by pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interleukin-1β. We investigated whether the pro-inflammatory cytokine TWEAK (TNF-like weak inducer of apoptosis) enhanced TGF-β1-induced EMT in the human bronchial epithelial cell line BEAS-2B.MethodsQuantitative RT-PCR and western blotting were used to define alterations in epithelial and mesenchymal marker expression in BEAS-2B cells. The cells were assessed for 48?h after stimulation with TGF-β1 alone or in combination with TWEAK.ResultsTGF-β1 induced spindle-like morphology and loss of cell contact, and reduced the expression of epithelial marker E-cadherin and increased the expression of mesenchymal markers N-cadherin and vimentin. Our data, for the first time, show that TWEAK reduced the expression of E-cadherin, and that co-treatment with TGF-β1 and TWEAK enhanced the TGF-β1-induced features of EMT. Moreover, hyaluronan synthase 2 expression was up-regulated by a combination with TGF-β1 and TWEAK, but not TNF-α. We also demonstrated that the Smad, p38 MAPK, and NF-κB signaling pathways, and the transcriptional repressor ZEB2 might mediate N-cadherin up-regulation by TGF-β1 in combination with TWEAK.ConclusionsThese findings suggest that the pro-inflammatory cytokine TWEAK and TGF-β1 have synergistic effects in EMT and may contribute to chronic airway changes and remodeling.Electronic supplementary materialThe online version of this article (doi:10.1186/s12931-015-0207-5) contains supplementary material, which is available to authorized users.
机译:背景技术慢性气道炎症性疾病,例如哮喘,以气道炎症和重塑为特征。慢性炎症和对气道上皮的损害导致气道重塑,这与不当的上皮修复有关,并且其特征在于转化生长因子-β(TGF-β)的表达升高。上皮-间质转化(EMT)是胚胎发育和组织重构期间的重要机制,通过上皮标记的下调和间充质标记的上调,上皮细胞具有增加运动能力的能力。 TGF-β是EMT的主要诱导剂,TGF-β诱导的EMT被促炎性细胞因子(包括肿瘤坏死因子-α(TNF-α)和白介素-1β)增强。我们研究了促炎性细胞因子TWEAK(TNF样凋亡的弱诱导剂)是否增强了TGF-β1诱导的人支气管上皮细胞系BEAS-2B的EMT。方法采用定量RT-PCR和Western blotting来确定上皮细胞的变化和间充质标志物在BEAS-2B细胞中的表达。 TGF-β1单独或与TWEAK联合刺激后,评估细胞48?h。结果TGF-β1诱导纺锤样形态和细胞接触丧失,并降低上皮标记物E-钙黏着蛋白的表达并增加TGF-β1的表达。间充质标记物N-钙黏着蛋白和波形蛋白。我们的数据首次显示TWEAK降低了E-钙粘蛋白的表达,并且与TGF-β1和TWEAK共同处理增强了TGF-β1诱导的EMT特性。而且,透明质酸合酶2的表达通过与TGF-β1和TWEAK的组合而被上调,但是与TNF-α的组合不被上调。我们还证明了Smad,p38 MAPK和NF-κB信号通路以及转录阻遏物ZEB2可能介导TGF-β1与TWEAK联合作用使N-钙黏着蛋白上调。 TGF-β1在EMT中具有协同作用,可能有助于慢性气道改变和重塑。电子补充材料本文的在线版本(doi:10.1186 / s12931-015-0207-5)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号